Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection

Lancet

Volumn 357, Issue 9252, 2001, Pages 280-281

  Lafeuillade, Alain ^a   Hittinger, Gilles ^a   Chadapaud, Stephane ^a  

^a Hopital Chalucet Toulon   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; NUCLEOSIDE ANALOG; RIBAVIRIN;

ANEMIA; ARTICLE; CASE REPORT; COMORBIDITY; DETERIORATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MIXTURE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDEMIA; MITOCHONDRIAL TOXICITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SUPERINFECTION;

EID: 0035956691     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03618-7     Document Type: Article

References (5)

1. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
2. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome
3. Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice
4. Toxicologic effects of ribavirin in cats
5. Hepatic failure and lactic acidosis due to Fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B